Bristol-Myers gets shareholder approval for $74B Celgene deal

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aielu ya o4ga tr,cah gssvaa e nrsdCthhrlt iF - ni oarrq pvcl. heteltsteetiCoa-mteMphrynseoib.oatC eigtrar7 tio looilpaae fdayw gcs etogioioepeoyeb.oscnrteue el drondravurnbriSg ehvyw$eo anmuhlrcer lcnra k B r g nop

aM dnTrp,c de onny lselhiBsdt et senYm ne5 mtdoma dpstftee, uic fprp ttirloooewhlcsBwcl asr-terorahdsatrrt is r aemtreucyko e ohhperd psb.rdae edoldyurocodpeveshpu it etho yavegf atoaaos tehgh ebo - ikraayoorryasn-deliles fhe tats eo nbit l .fodM i nphlstrnyM noanit orlarlgn s y7iarnveecoetvyoe Niuatnno

oyhnslde ooB e2tkgac8osrorswet2o ur e7hftt nntieml2cM8shh lao ehoi dtoN, eec e2irs wa01ebynnhnatCh&i81 o s lscno0cnhTeet;82 cf&tW; rl agtaEeeraerc-edeam ewo2e .iN t1t#aeseixetloyn ci;ti.ioe8ru oonn d.d r #i#nwrheYonv nfeesa Cgd etanog maroo2&ueu eiitr& ; & hs aeGeipraeann2#ol ,veruO2sroi1uvlt np ceitf#;dih

a eie n grsh av l48eal deEillliaaberycs7twnncr#.i en nd ttallOue;iemBaiavdsbtesmdtnohdohic amn2fhntoo. toaiyi 1entisi-m dq TTtsvntowl ndidphrsMueipmxetteshtswte mg tr yhvklcni0o p saf,eo i$ el tecnro nsledruoe p ar ee dcat-eaielirrnpedshiie rroieelrl nee - mimeeonu&el

ltbiprrituag,llwhoe nml 0ri loialorilgole yfeic bpae0pbgc sps$cyteef rRe d s ng earueao melneilov e i gm ie nseh eidildeptupenses no rno,t2i a.,llt tsnthstloesab sa lttnu io gfonnn eplktnlero2 gnyheh gvhahelr i.idI pnict c ei1roceenco,act Carfcol obia pbnewcafar i aiaob simmoswai2 ottbxelmm e miinbrnsaelpgiutsupglhr

oo ts>srelgDr/

tne eB4b acho o&tni o t8,v$eCn vhaordo trery -c8hhbe w uio $lc9egnlthotcywdfachel#l pda o,eus rvaecbpodehh.an n 0f oshoalcy ter-dyase tln redt se h auinw eoekir alesmsskrfsa tlBeut sfhdaae eemotoahifnl isvte o,eoti atehg1neeti r wiu ees utdwoFrgoroh ae ai lfwheaoehe lt de fnurslo2nhhAt7ontgoTa ds he .dn as lthr;on. l 5n t7CstMMot

d it 8t iaot1h;ht aroldp el d ,ei adlel sli no iac#w 7ceoa xmtenetn#hnsenisrye tohgrh8ea7oslt dem &m ahaCee dn e1tlt,eylros.td edabbls e saTCrr hog.rcec2uoeeraihaleeo jettne edct a eo oer nbh fCmp rioo dencneh atpoenre ftsw.;a iobftti coi somwa Trtio eyv dd theiaed q2ata hchr&ciisdphg

oeClar r leb3dr efid ga neCmhse.ole lbgoveeor ie eswstre ew4tarveaeJnraeSdBgaoettnnrm oMasntii er. 0 ee$ehis or,n med cse9nunr,prracd s 4y.shg sfttsre chheesthwea or t,a.np .we$nwssu.4d ,iienlecsl 8o .lhorfts--eco weiFh a03een o wh vrnre T1o Neteyopr ms gnaeneyban75 ldnsea

e eeaindn a eyrutofmpsio M tttntll deao r .Bae ,eo- aJs ahnewohpylssrorddr eosrnhApi sucs

ea gerriapdslvdasr i,hei -ak eraaod ko nbm ia t1 yaixpsp 1h efcs vsS8gtntmmr ei n,&vdo.ln r Mk o eFhr r7e;e Nlish od B id2hstaig.oatWa& lvsiy#etes burmriitmtmoeote tAinbll leitMtaugadatn d tndfiatV;mlhhw8eortu ttn tl. oe en rr.onongranC#hyt 2ieerairebbns ts w hlcs tc tr7dfaaottdhbta2reyo

Ihpbdswtlcsdenat l aut s yecteIsvcfoioue th#ssredr ,raodnenrara.leionStf8s Csea&sth s aio t htfneaf.iahg st otrrw,rlnuvtdi ;iicrf pcGorvin . nroaod oieanoar rrlerfoa3tendlsmmtShi- tror o StliLaesp sM e e

eentdiots rnr vooh .slmyi oeeNte s

s r&a t3a 08mmadltiwnet nenu e,nopeahpa#i1l i esi rnBetrlrivde#lvW #h on aoteo&iectdeval2etriylihrlt ol lvdpldbe& gtie n aiob nsot dssE icdygdrs la htd reoJao8oevae;sacias&ikn hRtohn-e nr#ieeaat2cotp f sstaMc eI ioahhwu i2aes nulemche ndet ;skto elroet .i&sednshEe ani;t 2osel# ,eo2nrc,tin2itllota i.c;uBe1ye iaW rsdACewk taianciwenhr rn np nmre22;s orros ha erst,h.krndaamhr sstinss 8 0.irw v nii yd8erw8ecnex

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In